Work begins on new $35 million R&D facility for expanding Douglas Pharmaceuticals

+News

Work begins on new $35 million R&D facility for expanding Douglas Pharmaceuticals

Fiona Cassie

Fiona Cassie

Douglas Pharmaceuticals new facility
Architect’s impression of Douglas Pharmaceuticals’ new $35 million research and development facility due to open in West Auckland in August, 2020
A clinical trial on using the controversial drug ketamine to treat depression is one of the projects to benefit from Douglas Pharmaceuticals new $35 m